TY - JOUR
T1 - Estimating the incidence, prevalence and true cost of asthma in the UK
T2 - Secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales-A study protocol
AU - Mukherjee, Mome
AU - Gupta, Ramyani
AU - Farr, Angela
AU - Heaven, Martin
AU - Stoddart, Andrew
AU - Nwaru, Bright I.
AU - Fitzsimmons, Deborah
AU - Chamberlain, George
AU - Bandyopadhyay, Amrita
AU - Fischbacher, Colin
AU - Dibben, Christopher
AU - Shields, Michael
AU - Phillips, Ceri
AU - Strachan, David
AU - Davies, Gwyneth
AU - McKinstry, Brian
AU - Sheikh, Aziz
AU - McClelland, Katie
AU - Hamilton, Kyle
AU - Burgess, Kerri
AU - Stewart, Rachel
AU - McVeigh, Suzanna
AU - Murray, Penny
AU - Gingles, Jenny
AU - Maguire, John
AU - Kennedy, Christine
AU - Myers, Jennifer
AU - Doole, Carrie
AU - Rosato, Michael
AU - Brunton, Carole
AU - Walsh, Claire
AU - McKeown, Neil
AU - Fitzpatrick, Sandy
AU - McLoughlin, Ricky
AU - Vitty, Alison
AU - Copyright, Crown
AU - Batchelor, Jodie
AU - McShane, Phil
AU - Fleming, Sarah
AU - Parslow, Roger
AU - Robinson, Emily
AU - Hickford, Donna
AU - Dingle, Helen
AU - Lloyd-Scott, Lucy
AU - Harrison, David
AU - Martin, Paul
AU - Hussey, Louise
AU - Burden and True Cost of Asthma in the UK Research Team
A2 - Price, David
A2 - Devereux, Graham
A2 - Steiner, Markus
PY - 2014/11
Y1 - 2014/11
N2 - Introduction: Asthma is now one of the most common long-term conditions in the UK. It is therefore important to develop a comprehensive appreciation of the healthcare and societal costs in order to inform decisions on care provision and planning. We plan to build on our earlier estimates of national prevalence and costs from asthma by filling the data gaps previously identified in relation to healthcare and broadening the field of enquiry to include societal costs. This work will provide the first UK-wide estimates of the costs of asthma. In the context of asthma for the UK and its member countries (ie, England, Northern Ireland, Scotland and Wales), we seek to: (1) produce a detailed overview of estimates of incidence, prevalence and healthcare utilisation; (2) estimate health and societal costs; (3) identify any remaining information gaps and explore the feasibility of filling these and (4) provide insights into future research that has the potential to inform changes in policy leading to the provision of more cost-effective care. Methods and analysis: Secondary analyses of data from national health surveys, primary care, prescribing, emergency care, hospital, mortality and administrative data sources will be undertaken to estimate prevalence, healthcare utilisation and outcomes from asthma. Data linkages and economic modelling will be undertaken in an attempt to populate data gaps and estimate costs. Separate prevalence and cost estimates will be calculated for each of the UKmember countries and these will then be aggregated to generate UK-wide estimates. Ethics and dissemination: Approvals have been obtained from the NHS Scotland Information Services Division's Privacy Advisory Committee, the Secure Anonymised Information Linkage Collaboration Review System, the NHS South-East Scotland Research Ethics Service and The University of Edinburgh's Centre for Population Health Sciences Research Ethics Committee. We will produce a report for Asthma-UK, submit papers to peer-reviewed journals and construct an interactive map.
AB - Introduction: Asthma is now one of the most common long-term conditions in the UK. It is therefore important to develop a comprehensive appreciation of the healthcare and societal costs in order to inform decisions on care provision and planning. We plan to build on our earlier estimates of national prevalence and costs from asthma by filling the data gaps previously identified in relation to healthcare and broadening the field of enquiry to include societal costs. This work will provide the first UK-wide estimates of the costs of asthma. In the context of asthma for the UK and its member countries (ie, England, Northern Ireland, Scotland and Wales), we seek to: (1) produce a detailed overview of estimates of incidence, prevalence and healthcare utilisation; (2) estimate health and societal costs; (3) identify any remaining information gaps and explore the feasibility of filling these and (4) provide insights into future research that has the potential to inform changes in policy leading to the provision of more cost-effective care. Methods and analysis: Secondary analyses of data from national health surveys, primary care, prescribing, emergency care, hospital, mortality and administrative data sources will be undertaken to estimate prevalence, healthcare utilisation and outcomes from asthma. Data linkages and economic modelling will be undertaken in an attempt to populate data gaps and estimate costs. Separate prevalence and cost estimates will be calculated for each of the UKmember countries and these will then be aggregated to generate UK-wide estimates. Ethics and dissemination: Approvals have been obtained from the NHS Scotland Information Services Division's Privacy Advisory Committee, the Secure Anonymised Information Linkage Collaboration Review System, the NHS South-East Scotland Research Ethics Service and The University of Edinburgh's Centre for Population Health Sciences Research Ethics Committee. We will produce a report for Asthma-UK, submit papers to peer-reviewed journals and construct an interactive map.
UR - http://www.scopus.com/inward/record.url?scp=84912077341&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2014-006647
DO - 10.1136/bmjopen-2014-006647
M3 - Article
C2 - 25371419
AN - SCOPUS:84912077341
SN - 2044-6055
VL - 4
JO - BMJ Open
JF - BMJ Open
IS - 11
M1 - e006647
ER -